Methods and compositions for treating a bleeding event in a subject having hemophilia
TW202626069APending Publication Date: 2026-07-01GENZYME CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115102673
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-05-18
- Filing Date
- 2018-07-10
- Publication Date
- 2026-07-01
Abstract
The invention relates to iRNA, e.g., double stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to treat a bleeding event in a subject having a hemophilia (e.g., with or without inhibitors).
Need to check novelty before this filing date? Find Prior Art